ArticleCutaneous Adverse Reaction to Infliximab: Report of Psoriasis Developing in 3 PatientsAuthor:Lawlor THPublish date: September 1, 2007 Infliximab is a chimeric immunoglobulin G1κ monoclonal antibody against tumor necrosis factor α (TNF-α), a proinflammatory cytok...Read More